(Q42544602)

English

The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats

scientific article published on January 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

author name string

V Kayser

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

J J Idänpään-Hekkilä

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

D Christensen

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

G Guilbaud

4

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

language of work or name

0 references

publication date

1 January 1998

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

947-952

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Pharmacology of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rats with a peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Behavioural evidence that systemic morphine may modulate a phasic pain-related behaviour in a rat model of peripheral mononeuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Evidence for a peripheral component in the enhanced antinociceptive effect of a low dose of systemic morphine in rats with peripheral mononeuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

The antinociceptive activity of kappa- but not delta-opioid receptor agonists is maintained in morphine-tolerant neuropathic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Cholecystokinin and morphine analgesia: variations on a theme

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

In mononeuropathic rats, the enhancement of morphine antinociception by L-365,260, a selective CCK(B) receptor antagonist, depends on the dose of systemic morphine and stimulus characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Ethical guidelines for investigations of experimental pain in conscious animals

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Repeated low doses of morphine induce a rapid tolerance in arthritic rats but a potentiation of opiate analgesia in normal animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Dependence in the absence of tolerance to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Morphine dependence with or without tolerance in formalin-treated mice: further evidence for the dissociation.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Anatomically distinct opiate receptor fields mediate reward and physical dependence.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Neural substrates of opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Effects of cholecystokinin receptor agonist and antagonists on morphine dependence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2898%2900012-5

7 January 2021

Identifiers

10.1016/S0024-3205(98)00012-5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42544602&oldid=1961288046"